Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

FDA approval for Vaprisol in euvolemic hyponatremia

Jan. 2, 2006

New treatments for urological disorders claimed in recent Tanabe Seiyaku and Eisai patents

Dec. 21, 2005

New treatments for urinary incontinence claimed in recent patents

Dec. 13, 2005

Oral PDE5 inhibitor SLx-2101 begins phase IIa trial for erectile dysfunction

Dec. 2, 2005

Korean approval for udenafil in erectile dysfunction

Dec. 1, 2005

Steroid 5alpha-reductase inhibitors for BPH from Schering AG

Nov. 29, 2005

Tolvaptan for autosomal dominant polycystic kidney disease

Nov. 17, 2005

Update on the long-term safety of lanthanum carbonate in dialysis patients

Nov. 15, 2005

SEW-2871: An S1P1 receptor agonist with renoprotective actions in vivo

Nov. 15, 2005

Renoprotective effects of pyridavone

Nov. 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...